Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
experimental group:Furmonertinib
2 trials
Sponsors
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Hospital
, The First Affiliated Hospital of Soochow University
Conditions
Non-small cell lung cancer
Phase 2
A multicenter, open label, single arm study: furmonertinib as neoadjuvant therapy for resectable stage IIIA EGFR mutant lung adenocarcinoma
Recruiting
ChiCTR2100053119
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Hospital
Non-small cell lung cancer
Start: 2021-12-01
Updated: 2022-09-06
Unknown Phase
A multicenter, single-arm clinical study to evaluate the efficacy and safety of Furmonertinib treatment in patients with resectable multiple primary NSCLC after one-side R0 resection
Active, not recruiting
ChiCTR2300068802
The First Affiliated Hospital of Soochow University
Non-small cell lung cancer
Start: 2023-03-01
Updated: 2023-05-22